| sodium channel, voltage-gated, type 2, alpha 1 polypeptide | 
                BROMHEXINE | 
                Sodium Channel, Site 2 | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type XI, alpha | 
                BROMHEXINE | 
                Sodium Channel, Site 2 | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1, gamma | 
                BROMHEXINE | 
                Sodium Channel, Site 2 | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1, delta | 
                BROMHEXINE | 
                Sodium Channel, Site 2 | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H, member 8 | 
                AMITRIPTYLINE | 
                Potassium Channel HERG | 
                47% | 
                17.5894uM | 
                14.4106uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 6 | 
                AMITRIPTYLINE | 
                Potassium Channel HERG | 
                47% | 
                17.5894uM | 
                14.4106uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 7 | 
                AMITRIPTYLINE | 
                Potassium Channel HERG | 
                47% | 
                17.5894uM | 
                14.4106uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 2 | 
                AMITRIPTYLINE | 
                Potassium Channel HERG | 
                47% | 
                17.5894uM | 
                14.4106uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 5 | 
                AMITRIPTYLINE | 
                Potassium Channel HERG | 
                47% | 
                17.5894uM | 
                14.4106uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 3 | 
                AMITRIPTYLINE | 
                Potassium Channel HERG | 
                47% | 
                17.5894uM | 
                14.4106uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 4 | 
                AMITRIPTYLINE | 
                Potassium Channel HERG | 
                47% | 
                17.5894uM | 
                14.4106uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | 
                AMITRIPTYLINE | 
                Potassium Channel HERG | 
                47% | 
                17.5894uM | 
                14.4106uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | 
                AMITRIPTYLINE | 
                Potassium Channel HERG | 
                47% | 
                17.5894uM | 
                14.4106uM | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | 
                TRIHEXYPHENIDYL | 
                CYP450-3A4 Inhibition | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | 
                RIFAPENTINE | 
                CYP450-3A4 Inhibition | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | thromboxane A synthase 1 | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Thromboxane Synthetase | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Thromboxane Synthetase | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 | 
                ALPHA-NAPHTHOFLAVONE | 
                GABAA, Benzodiazepine, Central | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid A receptor, gamma 1 | 
                ALPHA-NAPHTHOFLAVONE | 
                GABAA, Benzodiazepine, Central | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid A receptor, pi | 
                ALPHA-NAPHTHOFLAVONE | 
                GABAA, Benzodiazepine, Central | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | AT hook, DNA binding motif, containing 1 (DBSS) | 
                ALPHA-NAPHTHOFLAVONE | 
                GABAA, Benzodiazepine, Central | 
                47% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | nitric oxide synthase 3, endothelial cell | 
                BENZOTHIAZYL DISULFIDE | 
                Nitric Oxide Synthase, Constitutive (cNOS) | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | arachidonate 15-lipoxygenase | 
                SULOCTIDIL | 
                Lipoxygenase 15-LO | 
                10% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Phenylalkylamine | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | A3 adenosine receptor | 
                CAFFEIC ACID PHENETHYL ESTER | 
                Adenosine A3 | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | aldo-keto reductase family 1, member B4 (aldose reductase) | 
                CHOLIC ACID | 
                Aldose Reductase | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | aldo-keto reductase family 1, member B1 (aldose reductase) | 
                CHOLIC ACID | 
                Aldose Reductase | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | 
                CHOLIC ACID | 
                Aldose Reductase | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | 
                CHOLIC ACID | 
                Aldose Reductase | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4A, cAMP specific | 
                FLAVOXATE | 
                Phosphodiesterase PDE4 | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4C, cAMP-specific | 
                FLAVOXATE | 
                Phosphodiesterase PDE4 | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4D | 
                FLAVOXATE | 
                Phosphodiesterase PDE4 | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4B, cAMP specific | 
                FLAVOXATE | 
                Phosphodiesterase PDE4 | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 
                TICLOPIDINE | 
                Dopamine Transporter | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Protein-tyrosine kinase, Fyn | 
                MEBENDAZOLE | 
                Protein Tyrosine Kinase, Fyn | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, alpha 4 polypeptide | 
                MEGESTROL ACETATE | 
                ATPase, Na+/K+ | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, alpha 3 polypeptide | 
                MEGESTROL ACETATE | 
                ATPase, Na+/K+ | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 
                MEGESTROL ACETATE | 
                ATPase, Na+/K+ | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, alpha 1 polypeptide | 
                MEGESTROL ACETATE | 
                ATPase, Na+/K+ | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, beta 1 polypeptide | 
                MEGESTROL ACETATE | 
                ATPase, Na+/K+ | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, beta 3 polypeptide | 
                MEGESTROL ACETATE | 
                ATPase, Na+/K+ | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, beta 2 polypeptide | 
                MEGESTROL ACETATE | 
                ATPase, Na+/K+ | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, (Na+)/K+ transporting, beta 4 polypeptide | 
                MEGESTROL ACETATE | 
                ATPase, Na+/K+ | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | endothelin receptor type A | 
                SULINDAC SULFIDE | 
                Endothelin ETA | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2C19 monooxygenase | 
                L-744832 | 
                CYP450-2C19 Inhibition | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2a | 
                EPERISONE | 
                Imidazoline I2, Central | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | 
                EPERISONE | 
                Imidazoline I2, Central | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | progesterone receptor | 
                FELODIPINE | 
                Progesterone | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | progesterone receptor | 
                FELODIPINE | 
                Progesterone | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | nuclear receptor subfamily 3, group C, member 1 | 
                FELODIPINE | 
                Glucocorticoid | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-1A2 monooxygenase | 
                LYSERGOL | 
                CYP450-1A2 Inhibition | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mitogen activated protein kinase 3 | 
                1-NAPHTHYL ISOTHIOCYANATE | 
                Protein Serine/Threonine Kinase, ERK1 | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 
                MITOXANTRONE | 
                Dopamine Transporter | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2b | 
                MITOTANE | 
                Adrenergic alpha2B | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2b | 
                TROPISETRON | 
                Adrenergic alpha2B | 
                45% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                LYSERGOL | 
                Calcium Channel Type L, Phenylalkylamine | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                LYSERGOL | 
                Calcium Channel Type L, Phenylalkylamine | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                LYSERGOL | 
                Calcium Channel Type L, Phenylalkylamine | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                LYSERGOL | 
                Calcium Channel Type L, Phenylalkylamine | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | 
                LYSERGOL | 
                Calcium Channel Type L, Phenylalkylamine | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | 
                LYSERGOL | 
                Calcium Channel Type L, Phenylalkylamine | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | 
                LYSERGOL | 
                Calcium Channel Type L, Phenylalkylamine | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H, member 8 | 
                DESIPRAMINE | 
                Potassium Channel HERG | 
                44% | 
                27.8497uM | 
                22.8166uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 6 | 
                DESIPRAMINE | 
                Potassium Channel HERG | 
                44% | 
                27.8497uM | 
                22.8166uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 7 | 
                DESIPRAMINE | 
                Potassium Channel HERG | 
                44% | 
                27.8497uM | 
                22.8166uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 2 | 
                DESIPRAMINE | 
                Potassium Channel HERG | 
                44% | 
                27.8497uM | 
                22.8166uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 5 | 
                DESIPRAMINE | 
                Potassium Channel HERG | 
                44% | 
                27.8497uM | 
                22.8166uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 3 | 
                DESIPRAMINE | 
                Potassium Channel HERG | 
                44% | 
                27.8497uM | 
                22.8166uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 4 | 
                DESIPRAMINE | 
                Potassium Channel HERG | 
                44% | 
                27.8497uM | 
                22.8166uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | 
                DESIPRAMINE | 
                Potassium Channel HERG | 
                44% | 
                27.8497uM | 
                22.8166uM | 
              
              
                View
               | 
              
            
          
            
                | potassium voltage-gated channel, subfamily H (eag-related), member 1 | 
                DESIPRAMINE | 
                Potassium Channel HERG | 
                44% | 
                27.8497uM | 
                22.8166uM | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | 
                CLENBUTEROL | 
                CYP450-3A4 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | 
                LOSARTAN | 
                CYP450-3A4 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | opioid receptor, kappa 1 | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Opiate kappa | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D1A | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Dopamine D1 | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1A | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Serotonin 5-HT1A | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | epidermal growth factor receptor | 
                BETA-NAPHTHOFLAVONE | 
                Protein Tyrosine Kinase, EGF Receptor | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | 
                VINDESINE | 
                CYP450-3A4 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | acetylcholinesterase (YT blood group) | 
                SULOCTIDIL | 
                Acetylcholinesterase | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | 
                SULOCTIDIL | 
                Acetylcholinesterase | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | acetylcholinesterase | 
                SULOCTIDIL | 
                Acetylcholinesterase | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cholinergic receptor, muscarinic 4 | 
                TERFENADINE | 
                Muscarinic M4 | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 
                VALETHAMATE BROMIDE | 
                Dopamine Transporter | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | 
                IVERMECTIN | 
                CYP450-3A4 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2D6 monooxygenase | 
                PINDOLOL | 
                CYP450-2D6 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2D6 monooxygenase | 
                NALBUPHINE | 
                CYP450-2D6 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | 
                CLOBETASOL PROPIONATE | 
                CYP450-2C9 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | 
                CLOBETASOL PROPIONATE | 
                CYP450-2C9 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | 
                DIPHENIDOL | 
                Imidazoline I2, Central | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2a | 
                DIPHENIDOL | 
                Imidazoline I2, Central | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | A3 adenosine receptor | 
                3,3',4',5-TETRACHLOROSALICYLANILIDE | 
                Adenosine A3 | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D3 | 
                AMITRAZ | 
                Dopamine D3 | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | 
                STRYCHNINE | 
                Adrenergic alpha1D | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 1a | 
                MOXONIDINE | 
                Adrenergic alpha1A | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D4 | 
                MAPROTILINE | 
                Dopamine D4.2 | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cholinergic receptor, muscarinic 5 | 
                ALPHA-NAPHTHOFLAVONE | 
                Muscarinic M5 | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | opioid receptor, kappa 1 | 
                DIHYDROERGOCRISTINE MESYLATE | 
                Opiate kappa | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2b | 
                TERBINAFINE | 
                Adrenergic alpha2C | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | 
                TERBINAFINE | 
                Adrenergic alpha2C | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2a | 
                SUMATRIPTAN | 
                Adrenergic alpha2A | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | prostaglandin-endoperoxide synthase 2 | 
                ROSIGLITAZONE | 
                Cyclooxygenase COX-2 | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 
                ROSIGLITAZONE | 
                Cyclooxygenase COX-2 | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | monoamine oxidase A | 
                ROSIGLITAZONE | 
                Monoamine Oxidase MAOA | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | monoamine oxidase A | 
                ROSIGLITAZONE | 
                Monoamine Oxidase MAOA | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | 
                ETHYNODIOL DIACETATE | 
                CYP450-2C9 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | 
                ETHYNODIOL DIACETATE | 
                CYP450-2C9 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D4 | 
                METOCLOPRAMIDE | 
                Dopamine D4.2 | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2C19 monooxygenase | 
                ETHYNODIOL DIACETATE | 
                CYP450-2C19 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-1A2 monooxygenase | 
                PIPAMAZINE | 
                CYP450-1A2 Inhibition | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | chemokine (C-C motif) receptor 2 | 
                INDOMETHACIN | 
                Chemokine CCR2B | 
                44% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                KETOCONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                55% | 
                32.041uM | 
                28.481uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                KETOCONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                55% | 
                32.041uM | 
                28.481uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | 
                KETOCONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                55% | 
                32.041uM | 
                28.481uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | 
                KETOCONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                55% | 
                32.041uM | 
                28.481uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | 
                KETOCONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                55% | 
                32.041uM | 
                28.481uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | 
                KETOCONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                55% | 
                32.041uM | 
                28.481uM | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 
                FENOFIBRATE | 
                Adrenergic, Norepinephrine Transporter | 
                55% | 
                21.408uM | 
                21.231uM | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, beta 1 | 
                ERGOCORNINE | 
                Adrenergic beta1 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic, beta-1-, receptor | 
                ERGOCORNINE | 
                Adrenergic beta1 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 
                SIMVASTATIN | 
                Adrenergic, Norepinephrine Transporter | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 
                NOCODAZOLE | 
                Dopamine Transporter | 
                55% | 
                6.232uM | 
                4.946uM | 
              
              
                View
               | 
              
            
          
            
                | androgen receptor | 
                BISPHENOL A | 
                Testosterone | 
                55% | 
                33.796uM | 
                22.531uM | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | 
                ROTENONE | 
                CYP450-3A4 Inhibition | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | tachykinin receptor 2 | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Tachykinin NK2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Protein Serine/Threonine Phosphatase, Calcineurin PP2B | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Protein Serine/Threonine Phosphatase, Calcineurin PP2B | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Protein Serine/Threonine Phosphatase, Calcineurin PP2B | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Protein Serine/Threonine Phosphatase, Calcineurin PP2B | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | protein phosphatase 3, catalytic subunit, beta isoform | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Protein Serine/Threonine Phosphatase, Calcineurin PP2B | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Protein Serine/Threonine Phosphatase, Calcineurin PP2B | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | opioid receptor, kappa 1 | 
                PERHEXILINE | 
                Opiate kappa | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | 
                HEXACHLOROPHENE | 
                HMG-CoA Reductase | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | 
                HEXACHLOROPHENE | 
                HMG-CoA Reductase | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D3 | 
                PERHEXILINE | 
                Dopamine D3 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, beta | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, beta | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, alpha | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, beta | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel associated protein 1 | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel associated protein 2 | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type III, beta | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, alpha | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IX, alpha | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type VII, alpha | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | amiloride-sensitive cation channel 5, intestinal | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type III, beta | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type VIII, alpha polypeptide | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type XI, alpha | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, beta | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type 10, alpha polypeptide | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, alpha polypeptide | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type V, alpha polypeptide | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, beta | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1 alpha | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1 gamma | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1 beta | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type 2, alpha 1 polypeptide | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type XI, alpha | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1, gamma | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1, delta | 
                IODOQUINOL | 
                Sodium Channel, Site 2 | 
                55% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mu-opioid receptor MOR | 
                BENZTROPINE | 
                Opiate mu | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | 
                ABAMECTIN | 
                Calcium Channel Type L, Dihydropyridine | 
                54% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               |